Who sells it

Do Ro, Hims, Hers and WeightWatchers sell compounded tirzepatide?

Read from each brand’s own site on 11 September 2026

Ro¹

Ro’s weight-loss page lists only FDA-approved products: the Wegovy pill and pen, the Zepbound pen and KwikPen, Ozempic, and Foundayo. Its banner reads “FDA-approved GLP-1s at their lowest prices.” Its FAQ prices Zepbound at “$299/mo for 2.5 mg dose · $399/mo for 5 mg dose · $449/mo for 7.5 mg, 10 mg, 12.5 mg, and 15 mg doses (with manufacturer offer)”, with a membership as a separate charge: $39 the first month, then $74 to $149 a month.

Its terms of use, revised April 2026, still say members “may be prescribed compounded medication during national drug shortages” — a clause that depends on a shortage FDA declared over. The old compounded-semaglutide address on ro.co now redirects to a quiz.

Hims and Hers²

One company, two sites, one lineup. Both list only brand-name drugs — the Wegovy pill and pen, Zepbound vial and KwikPen, Foundayo, the Ozempic pill and pen, and Mounjaro — each priced for the medication alone, with “An active Hims Weight Loss Membership is required ($39 for the first month, auto-renews at $149/month thereafter).” The old compounded-semaglutide page on hims.com redirects to that brand-only grid.

The company’s investor site is where compounded medicine still appears. In March 2026 it said it would “offer compounded semaglutide through the platform on a limited scale”, would “no longer advertise compounded GLP-1 offerings”, and would offer compounded GLP-1s only “if a provider determines that a compounded product is clinically necessary.” None of its statements names compounded tirzepatide.

WeightWatchers³

WeightWatchers says it outright: “WeightWatchers is no longer offering access to compounded semaglutide.” It sells brand-name drugs through its Med+ membership — Zepbound “Self pay starting at $299/mo” on its homepage, though its tirzepatide page still says “Starting at $349/month” — with Med+ at $25 for the first month on a 6- or 12-month plan, then $74 or $84 a month. It says nothing about compounded tirzepatide.

What the brand route costs⁴

The brand route through these companies is two charges: the drug and the membership. At Ro, Zepbound at 7.5 mg and above is $449 a month on its own figures, and the monthly membership is $149 — $598 a month together, or less on an annual membership. The median compounded tirzepatide month in this index is $272, with nothing charged on top at most sellers.

That is a comparison of price, not of product: Zepbound is the approved drug, with the label, manufacturing review and trials a compounded vial does not have — see compounded tirzepatide vs Zepbound. What Lilly itself charges for Zepbound direct, dose by dose, is on is compounded tirzepatide still cheaper than Zepbound?

Brands in this index that do sell it⁴

Several names readers know do list compounded tirzepatide. What each one bills per calendar month, from its own checkout or pricing page:

• Mochi Health — $178 a month
• Henry Meds — $301 a month
• Fridays — $364 a month
• Eden — $298 a month
• Found — $289 a month
• HealthOn — $315 a month
• Ivim Health — $355 a month

Every other seller is on the index, ordered by what a month actually costs. Why the big brands pulled back is the shortage ending — the dated record is on is compounded tirzepatide still legal?

What a brand sells changes; every statement here is dated to the day its own site was read. Price information only, not medical advice.